Vontobel Holding Ltd. Regenxbio Inc. Transaction History

Vontobel Holding Ltd.

  • $29.4 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022
SELL
$22.29 - $35.04 $59,469 - $93,486
-2,668 Reduced 5.41%
46,639 $1.23 Million
Q2 2022

Jul 27, 2022
BUY
$19.35 - $35.04 $760,590 - $1.38 Million
39,307 Added 393.07%
49,307 $1.22 Million
Q4 2020

Feb 12, 2021
BUY
$26.52 - $49.35 $265,200 - $493,500
10,000 New
10,000 $454,000

Others Institutions Holding RGNX

# of Institutions
193
Shares Held
43.5M
Call Options Held
58.9K
Put Options Held
58.4K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $404M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email